在患有多发性骨髓瘤和功能受损的患者中使用特克利斯塔马布
Laura Joiner1, Susan Bal2, Kelly N Godby2
1Department of Pharmacy, University of Alabama at Birmingham, Birmingham, Alabama, USA.
American journal of hematology
|August 24, 2023
概括
德克利斯塔马布在患有严重脏问题的患者中表现出强烈的抗髓瘤作用. 这种双特异性抗体为这一患者群提供了新的治疗选择.
科学领域:
- 在瘤学瘤学.
- 腎臟病學 (nephrology) 是一種醫學專業.
背景情况:
- 多发性骨髓瘤是一种血液性恶性瘤,对患有功能障碍的患者来说,治疗选择有限.
- 严重的功能障碍在药物选择和剂量方面带来了挑战,因为药物动力学发生了变化.
相关概念视频
Renal Failure: Dose Adjustments
121
In patients with renal impairment, drugs undergo significant changes in their pharmacokinetics, which require dosage adjustments to ensure safe and effective therapy.
Reduced renal clearance and elimination rate are common outcomes of renal impairment. These alterations lead to a prolonged elimination half-life and an altered apparent volume of distribution for drugs. As a result, dosage adjustments are typically necessary to maintain optimal drug levels in the body.
However, dosage adjustments...
Reduced renal clearance and elimination rate are common outcomes of renal impairment. These alterations lead to a prolonged elimination half-life and an altered apparent volume of distribution for drugs. As a result, dosage adjustments are typically necessary to maintain optimal drug levels in the body.
However, dosage adjustments...
121
Tumor Immunotherapy
556
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
556
![Dynamic Imaging of Chimeric Antigen Receptor T Cells with [18F]Tetrafluoroborate Positron Emission Tomography/Computed Tomography](/_next/image?url=https%3A%2F%2Fcloudfront.jove.com%2FCDNSource%2Fteasers%2F62334.jpg&w=3840&q=50)

